DZ2600A1 - Associations pharmaceutiques d'amlodipine et d'unestatine et procédé pour leur préparation. - Google Patents

Associations pharmaceutiques d'amlodipine et d'unestatine et procédé pour leur préparation.

Info

Publication number: DZ2600A1
Authority: DZ; Algeria
Prior art keywords: estatin; amlodipine; preparation; pharmaceutical combinations; pharmaceutical
Prior art date: 1997-08-29

Application number

DZ980210A

Other languages

English (en)

Inventor

Jan Buch

Robert Andrew Donald Scott

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-29

Filing date

1998-08-26

Publication date

2003-03-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22011309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2600(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-08-26 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2003-03-01 Application granted granted Critical

2003-03-01 Publication of DZ2600A1 publication Critical patent/DZ2600A1/fr

Links

229930195048 Estatin Natural products 0.000 title 1
HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 title 1
229960000528 amlodipine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Pulmonology (AREA)
Hematology (AREA)
Diabetes (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Iron Core Of Rotating Electric Machines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Electrotherapy Devices (AREA)
Medicines Containing Plant Substances (AREA)

DZ980210A 1997-08-29 1998-08-26 Associations pharmaceutiques d'amlodipine et d'unestatine et procédé pour leur préparation. DZ2600A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US5755597P	1997-08-29	1997-08-29

Publications (1)

Publication Number	Publication Date
DZ2600A1 true DZ2600A1 (fr)	2003-03-01

Family

ID=22011309

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ980210A DZ2600A1 (fr)	1997-08-29	1998-08-26	Associations pharmaceutiques d'amlodipine et d'unestatine et procédé pour leur préparation.

Country Status (36)

Country	Link
US (1)	US20020025981A1 (fr)
EP (1)	EP1003507A1 (fr)
JP (1)	JP2001514224A (fr)
KR (1)	KR20010022385A (fr)
CN (1)	CN1117566C (fr)
AP (1)	AP1207A (fr)
AR (1)	AR017514A1 (fr)
AU (1)	AU744982B2 (fr)
BG (1)	BG104076A (fr)
BR (1)	BR9811558A (fr)
CA (1)	CA2296726C (fr)
CO (1)	CO4970726A1 (fr)
DZ (1)	DZ2600A1 (fr)
EA (1)	EA002705B1 (fr)
GT (1)	GT199800134A (fr)
HN (1)	HN1998000124A (fr)
HR (1)	HRP980475A2 (fr)
HU (1)	HUP0003103A3 (fr)
ID (1)	ID24275A (fr)
IL (2)	IL133957A0 (fr)
IS (1)	IS5345A (fr)
MA (1)	MA26539A1 (fr)
NO (1)	NO20000999D0 (fr)
NZ (1)	NZ502283A (fr)
OA (1)	OA11289A (fr)
PA (1)	PA8457201A1 (fr)
PE (1)	PE106999A1 (fr)
PL (1)	PL339088A1 (fr)
SA (1)	SA98190432A (fr)
SK (1)	SK1392000A3 (fr)
TN (1)	TNSN98158A1 (fr)
TR (1)	TR200000562T2 (fr)
UY (1)	UY25159A1 (fr)
WO (1)	WO1999011263A1 (fr)
YU (1)	YU2700A (fr)
ZA (1)	ZA987843B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH07506822A (ja)	1992-05-19	1995-07-27	ノボゲン　リサーチ　ピーティーワイ　リミッテッド	フィト−エストロゲン，類似体またはその代謝産物を含有する健康補助剤
US6642268B2 (en)	1994-09-13	2003-11-04	G.D. Searle & Co.	Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
AUPO203996A0 (en)	1996-08-30	1996-09-26	Novogen Research Pty Ltd	Therapeutic uses
AU3103800A (en)	1998-12-23	2000-07-31	G.D. Searle Llc	Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acidderivatives for cardiovascular indications
EP1076091A1 (fr) *	1999-08-09	2001-02-14	Universite Catholique De Louvain	Composé ou composition pharmaceutique pour la prévention et/ou le traitement d'ischémie cardiaque, de maladies vasculaires périphériques, de tumeurs et de plaies
AUPQ266199A0 (en)	1999-09-06	1999-09-30	Novogen Research Pty Ltd	Compositions and therapeutic methods involving isoflavones and analogues thereof
DE19944803A1 (de) *	1999-09-20	2001-03-29	Bayer Ag	Kombination von Dihydropyridinverbindungen und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
EP1314425A4 (fr) *	2000-08-30	2004-06-02	Sankyo Co	Compositions medicinales utilisees dans la prevention ou le traitement de l'insuffisance cardiaque
AUPR255401A0 (en) *	2001-01-16	2001-02-08	Novogen Research Pty Ltd	Regulation of lipids and/or bone density and compositions therefor
AUPR363301A0 (en)	2001-03-08	2001-04-05	Novogen Research Pty Ltd	Dimeric isoflavones
US20030114497A1 (en) *	2001-07-31	2003-06-19	Laman Alani	Pharmaceutical compositions of amlodipine and atorvastatin
MXPA04006255A (es)	2002-01-17	2004-09-27	Pharmacia Corp	Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato.
NL1019882C2 (nl) *	2002-02-01	2003-08-04	Synthon Licensing	Amlodipine vrije base.
US20040053842A1 (en) *	2002-07-02	2004-03-18	Pfizer Inc.	Methods of treatment with CETP inhibitors and antihypertensive agents
US7071210B2 (en) *	2002-07-02	2006-07-04	Pfizer Inc.	CETP inhibitors in combination with antihypertensive agents and uses thereof
GB0322552D0 (en)	2003-09-26	2003-10-29	Astrazeneca Uk Ltd	Therapeutic treatment
WO2005097191A2 (fr) *	2004-04-04	2005-10-20	Sepracor Inc.	Combinaisons comprenant de la (s)-amlodipine et un inhibiteur de la hmg-coa reductase ou un inhibiteur de l'absorption de cholesterol ou les deux a la fois et methodes permettant de reduire l'hypertension
KR100582347B1 (ko) *	2004-12-30	2006-05-22	한미약품 주식회사	3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법
KR100742432B1 (ko) *	2005-12-27	2007-07-24	한미약품 주식회사	암로디핀 캠실레이트 및 심바스타틴을 포함하는 복합제제,및 이의 제조방법
WO2007111027A1 (fr) *	2006-03-29	2007-10-04	Kowa Co., Ltd.	Agent favorisant la baisse des triglycérides et agent améliorant l'hyperinsulinisme
WO2008023869A1 (fr) *	2006-08-24	2008-02-28	Hanall Pharmaceutical Co., Ltd.	PRÉPARATION PHARMACEUTIQUE COMBINÉE À LIBÉRATION CONTRÔLÉE COMPRENANT DES INHIBITEURS CALCIQUES À BASE DE DIHYDROPYRIDINE ET DES INHIBITEURS DE HMG-CoA RÉDUCTASE
WO2008023958A1 (fr) *	2006-08-24	2008-02-28	Hanall Pharmaceutical Co., Ltd.	Composition pharmaceutique combinée à libération contrôlée comprenant de la dihydropyridine, des bloqueurs de canal calcium et des inhibiteurs de l'hgm-coa réductase
MX2007008440A (es) *	2007-07-11	2009-02-18	Senosiain S A De C V Lab	Composicion farmaceutica combinada.
KR101207618B1 (ko) *	2008-02-22	2012-12-04	한올바이오파마주식회사	심혈관계 질환 치료용 약제학적 제제
WO2009125987A2 (fr) *	2008-04-10	2009-10-15	한올제약주식회사	Préparation pharmaceutique
WO2010008203A2 (fr) *	2008-07-15	2010-01-21	한올제약주식회사	Preparation pharmaceutique contenant un inhibiteur des canaux calciques
CN101804055B (zh) *	2010-04-27	2012-01-25	施慧达药业集团(吉林)有限公司	复方药物制剂
US20190263888A1 (en)	2010-10-19	2019-08-29	Op-T Llc	Therapeutic peptides and methods for treating autoimmune related disease
EP2629797B1 (fr)	2010-10-19	2018-05-23	The Regents of the University of Colorado, A Body Corporate	Peptides modulant l'activité des lymphocytes t et leurs utilisations
ES2905872T3 (es)	2015-02-06	2022-04-12	Intercept Pharmaceuticals Inc	Composiciones farmacéuticas para terapia combinada
WO2019094581A1 (fr) *	2017-11-10	2019-05-16	Op-T Llc	Procédés de prévention, de modulation et/ou de réduction d'une maladie cardiovasculaire
US11793854B2 (en)	2019-03-21	2023-10-24	Op-T Llc	Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD150 interaction
WO2021108343A1 (fr) *	2019-11-25	2021-06-03	Fordoz Pharma C0Rp.	Formulations comprenant des médicaments abaissant les lipides et abaissant la pression sanguine
US12048734B2 (en)	2020-04-17	2024-07-30	Op-T Llc	Bioactive peptides and methods of use thereof
CN112826937B (zh) *	2021-03-25	2022-03-22	山东大学齐鲁医院	艾地苯醌与他汀类药物联用在防治动脉粥样硬化中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IN176897B (fr) *	1993-10-29	1996-09-28	Cadila Lab Ltd
DE19539363A1 (de) *	1995-10-23	1997-04-24	Basf Ag	Verfahren zur Herstellung von festen Arzneiformen

1998
- 1998-08-10 YU YU2700A patent/YU2700A/sh unknown
- 1998-08-10 AU AU84585/98A patent/AU744982B2/en not_active Ceased
- 1998-08-10 AP APAP/P/1998/001333A patent/AP1207A/en active
- 1998-08-10 NZ NZ502283A patent/NZ502283A/en unknown
- 1998-08-10 TR TR2000/00562T patent/TR200000562T2/xx unknown
- 1998-08-10 ID IDW20000199A patent/ID24275A/id unknown
- 1998-08-10 IL IL13395798A patent/IL133957A0/xx unknown
- 1998-08-10 BR BR9811558-8A patent/BR9811558A/pt not_active Application Discontinuation
- 1998-08-10 JP JP2000508366A patent/JP2001514224A/ja active Pending
- 1998-08-10 HN HN1998000124A patent/HN1998000124A/es unknown
- 1998-08-10 PL PL98339088A patent/PL339088A1/xx unknown
- 1998-08-10 WO PCT/IB1998/001220 patent/WO1999011263A1/fr not_active Ceased
- 1998-08-10 CA CA002296726A patent/CA2296726C/fr not_active Expired - Fee Related
- 1998-08-10 SK SK139-2000A patent/SK1392000A3/sk unknown
- 1998-08-10 EP EP98935246A patent/EP1003507A1/fr not_active Withdrawn
- 1998-08-10 CN CN98808465A patent/CN1117566C/zh not_active Expired - Fee Related
- 1998-08-10 KR KR1020007000964A patent/KR20010022385A/ko not_active Ceased
- 1998-08-10 EA EA200000013A patent/EA002705B1/ru not_active IP Right Cessation
- 1998-08-10 HU HU0003103A patent/HUP0003103A3/hu unknown
- 1998-08-11 PA PA19988457201A patent/PA8457201A1/es unknown
- 1998-08-17 GT GT199800134A patent/GT199800134A/es unknown
- 1998-08-19 SA SA98190432A patent/SA98190432A/ar unknown
- 1998-08-24 PE PE1998000768A patent/PE106999A1/es not_active Application Discontinuation
- 1998-08-26 TN TNTNSN98158A patent/TNSN98158A1/fr unknown
- 1998-08-26 DZ DZ980210A patent/DZ2600A1/fr active
- 1998-08-26 MA MA25231A patent/MA26539A1/fr unknown
- 1998-08-27 CO CO98049137A patent/CO4970726A1/es unknown
- 1998-08-27 UY UY25159A patent/UY25159A1/es not_active Application Discontinuation
- 1998-08-27 AR ARP980104289A patent/AR017514A1/es unknown
- 1998-08-28 HR HR60/057,555A patent/HRP980475A2/hr not_active Application Discontinuation
- 1998-08-28 ZA ZA9807843A patent/ZA987843B/xx unknown
2000
- 2000-01-09 IL IL133957A patent/IL133957A/en unknown
- 2000-01-13 BG BG104076A patent/BG104076A/xx unknown
- 2000-01-14 IS IS5345A patent/IS5345A/is unknown
- 2000-02-18 OA OA1200000038A patent/OA11289A/en unknown
- 2000-02-28 NO NO20000999A patent/NO20000999D0/no not_active Application Discontinuation
2001
- 2001-10-10 US US09/975,765 patent/US20020025981A1/en not_active Abandoned

Also Published As

Publication number	Publication date
SK1392000A3 (en)	2000-08-14
TNSN98158A1 (fr)	2005-03-15
UY25159A1 (es)	2000-12-29
ID24275A (id)	2000-07-13
IL133957A0 (en)	2001-04-30
OA11289A (en)	2003-08-25
PE106999A1 (es)	1999-11-06
NO20000999L (no)	2000-02-28
CN1117566C (zh)	2003-08-13
HRP980475A2 (en)	1999-06-30
HUP0003103A2 (hu)	2001-01-29
AR017514A1 (es)	2001-09-12
HK1029530A1 (en)	2001-04-06
JP2001514224A (ja)	2001-09-11
IS5345A (is)	2000-01-14
SA98190432A (ar)	2005-12-03
AP1207A (en)	2003-09-20
AP9801333A0 (en)	1998-09-30
PL339088A1 (en)	2000-12-04
HUP0003103A3 (en)	2002-03-28
EA200000013A1 (ru)	2000-08-28
US20020025981A1 (en)	2002-02-28
ZA987843B (en)	2000-02-28
CO4970726A1 (es)	2000-11-07
TR200000562T2 (tr)	2000-08-21
BR9811558A (pt)	2000-08-22
NZ502283A (en)	2002-05-31
EP1003507A1 (fr)	2000-05-31
CA2296726A1 (fr)	1999-03-11
CN1268054A (zh)	2000-09-27
KR20010022385A (ko)	2001-03-15
PA8457201A1 (es)	2000-05-24
AU8458598A (en)	1999-03-22
YU2700A (sh)	2002-06-19
IL133957A (en)	2006-06-11
CA2296726C (fr)	2004-06-29
HN1998000124A (es)	1999-02-09
GT199800134A (es)	2000-02-08
WO1999011263A1 (fr)	1999-03-11
BG104076A (en)	2000-09-29
MA26539A1 (fr)	2004-12-20
NO20000999D0 (no)	2000-02-28
EA002705B1 (ru)	2002-08-29
AU744982B2 (en)	2002-03-07

Publication	Publication Date	Title
DZ2596A1 (fr)	2003-02-22	Associations pharmaceutiques d'amlodipine et d'atorvastatine et procédé pour leur préparation.
DZ2595A1 (fr)	2003-02-22	Associations de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs et procédépour leur préparation.
MA26539A1 (fr)	2004-12-20	Associations pharmaceutiques d'amlodipine et d'une statine, et procede pour leur preparation.
DZ2523A1 (fr)	2003-02-01	Formulations pharmaceutiques contenant du voriconazole et procédé pour leur préparation.
DZ2303A1 (fr)	2002-12-28	Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2745A1 (fr)	2003-09-08	BicycloÄ2.2.1Üheptanes nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1889A1 (fr)	2002-02-17	Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2773A1 (fr)	2003-12-01	Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2394A1 (fr)	2003-06-04	Dérivés de quinoléine et dérivés de quinazoline nouveax procédé pour leur préparation et compositions pharmaceutiques les contenant
DZ2358A1 (fr)	2002-12-28	Amides inhibiteurs de sécrétion de apo b/mtp procédé pour leur préparation et compositions pharmaceutiques les contenant
DZ2300A1 (fr)	2002-12-25	Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2299A1 (fr)	2002-12-25	Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2923A1 (fr)	2004-03-01	Formulations pharmaceutiques d'inhibiteurs de pde-5 de gmpc à libération contrôlée, et procédé pour leur préparation.
DZ2227A1 (fr)	2002-12-25	Dérivés d'indole nouveaux, procédé pour leur préparation et formulations pharmaceutiques les contenant.
DZ2666A1 (fr)	2003-03-22	Dérivés d'acide hydroxamique compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2634A1 (fr)	2003-03-08	Dérivés de pleuromutiline nouveaux procédé pour leur préparation et compositions pharmaceutiques lescontenant.
DZ2197A1 (fr)	2002-12-02	Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2407A1 (fr)	2003-01-04	Dérivés de sulfonylurée procédé pour leur préparation et compositions pharmaceutiques les contenant
DZ2420A1 (fr)	2003-01-04	Formulations nouvelles comprenant l'amoxycilline et du clavulanate et procédé pour leur préparation.
DZ2410A1 (fr)	2003-01-04	Dérivés d'acide arylsulfonylaminohydroxamique procédé pour leur préparation et compositions pharmaceutiques
DZ2457A1 (fr)	2004-11-08	Derivés de nicotinamide nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
DZ2186A1 (fr)	2002-12-02	Compositions pharmaceutiques mixtes pour le traitement de l'ostéoporose et procédé pour leur préparation.
FR2729951B1 (fr)	1997-04-18	Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
DZ1957A1 (fr)	2002-02-17	Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.